Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival by Abdelmagid, Maymona G, Al-Kali, Aref, Begna, Kebede H, Hogan, William J, Litzow, Mark R, Fleti, Farah, Mangaonkar, Abhishek A, Patnaik, Mrinal S, Elliott, Michelle A, Alkhateeb, Hassan, Shi, Min, Howard, Matthew T, Reichard, Kaaren K, Ketterling, Rhett P, Shah, Mithun, Pardanani, Animesh, Gangat, Naseema, Tefferi, Ayalew

Get full text

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases by Abdelmagid, Maymona G., Litzow, Mark R., McCullough, Kristen B., Gangat, Naseema, Pardanani, Animesh, Murthy, Hemant S., Foran, James M., Ketterling, Rhett P., Viswanatha, David, Begna, Kebede H., Tefferi, Ayalew

Get full text

Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusiv... by Abdelmagid, Maymona G., Al-Kali, Aref, Litzow, Mark R., Begna, Kebede H., Hogan, William J., Patnaik, Mirinal S., Hashmi, Shahrukh K., Elliott, Michelle A., Alkhateeb, Hassan, Karrar, Omer S., Fleti, Farah, Elnayir, Mohammed H., Rivera, Candido E., Murthy, Hemant S., Foran, James M., Kharfan-Dabaja, Mohamed A., Badar, Talha, Viswanatha, David S., Reichard, Kaaren K., Gangat, Naseema, Tefferi, Ayalew

Get full text

PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis by Tefferi, Ayalew, Fathima, Saubia, Alsugair, Ali Khalid A., Aperna, Fnu, Natu, Anuya, Abdelmagid, Maymona G., Csizmar, Clifford M., Gurney, Mark, Lasho, Terra L., Finke, Christy M., Mangaonkar, Abhishek A., Al‐Kali, Aref, Pardanani, Animesh, Reichard, Kaaren K., He, Rong, Gangat, Naseema, Patnaik, Mrinal M.

Get full text

Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases by Singh, Amritpal, Al‐Kali, Aref, Begna, Kebede H., Litzow, Mark R., Larsen, Jeremy T., Sher, Taimur, Abdelmagid, Maymona G., Farrukh, Faiqa, Reichard, Kaaren K., Gangat, Naseema, Pardanani, Animesh, Tefferi, Ayalew

Get full text

TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases by Fleti, Farah, Chan, Onyee, Singh, Amritpal, Abdelmagid, Maymona G., Al‐Kali, Aref, Elliott, Michelle A., Begna, Kebede H., Foran, James M., Badar, Talha, Khera, Nandita, Al Ali, Najla H., Padron, Eric, Sallman, David A., Shah, Mithun, Hiwase, Devendra, Pardanani, Animesh, Arber, Daniel A., Orazi, Attilio, Reichard, Kaaren K., He, Rong, Ketterling, Rhett P., Gangat, Naseema, Komrokji, Rami, Tefferi, Ayalew

Get full text